Conflict of interest and citation impact among dermatology guideline authors - 11/02/19
Doi : 10.1016/j.jaad.2018.10.028
Kamber Loren Hart, AB a, Roy Howard Perlis, MD, MSc b, Clifford Scott Perlis, MD, MBioethics c, ⁎ 
a Center for Quantitative Health, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
b Harvard Medical School Center for Quantitative Health, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
c Temple University Medical School, Keystone Dermatology Partners, King of Prussia, Pennsylvania
∗Reprint requests: Clifford Scott Perlis, MD, MBioethics, Keystone Dermatology Partners, 216 Mall Blvd, Ste 101, King of Prussia, PA 19406Keystone Dermatology Partners216 Mall BlvdSte 101King of PrussiaPA19406
| Funding sources: None. |
|
| Conflicts of interest: Dr R. Perlis has received consulting fees or served on the scientific advisory boards for Genomind, Psy Therapeutics, and RID Ventures, and he holds equity in Psy Therapeutics. Dr C. Perlis and Kamber Loren Hart have no conflicts of interest to disclose. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 80 - N° 3
P. 813-815 - mars 2019 Retour au numéro
Article précédent
- The cost of an itch: A nationally representative retrospective cohort study of pruritus-associated health care expenditure in the United States
- Raghav Tripathi, Konrad D. Knusel, Harib H. Ezaldein, Jeremy S. Bordeaux, Jeffrey F. Scott
- Development and implementation of an order set to improve value of care for patients with severe stasis dermatitis
- Susan Nedorost, Sheree White, Douglas Y. Rowland, Beth Bednarchik, Susan Flocke, Teresa L. Carman, Lauren Karpinski, Yiwen Shi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?